SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories’ Synriam wins Innovation Excellence Platinum Award

16 Jul 2013 Evaluate

Ranbaxy Laboratories, the country’s largest pharmaceutical company, has been conferred with the Innovation Excellence Platinum Award at the ASSOCHAM Innovation Awards 2013 in the Science & Technology category for its new anti-malaria drug, Synriam. The prestigious award was given by Minister for Science & Technology and Earth Sciences, Jaipal Reddy.

Synriam, was launched by the company last year on April 25 (World Malaria Day). The drug is used for the treatment of plasmodium falciparum malaria, in adults. The company is working to make this new treatment available in African, Asian and South American markets where Malaria is rampant.

As per IMS data, over 2 million Synriam pills have been sold since its launch and over 700,000 patients have been treated in India.

Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×